Non-genetic determinants of malignant clonal fitness at single-cell resolution DOI
Katie Fennell, Dane Vassiliadis, Enid Y.N. Lam

et al.

Nature, Journal Year: 2021, Volume and Issue: 601(7891), P. 125 - 131

Published: Dec. 8, 2021

Language: Английский

Epigenetics of colorectal cancer: biomarker and therapeutic potential DOI
Gerhard Jung, Eva Hernández‐Illán, Leticia Moreira

et al.

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2020, Volume and Issue: 17(2), P. 111 - 130

Published: Jan. 3, 2020

Language: Английский

Citations

620

Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma DOI Creative Commons
Zhaohui Chen, Lijie Zhou, Lilong Liu

et al.

Nature Communications, Journal Year: 2020, Volume and Issue: 11(1)

Published: Oct. 8, 2020

Although substantial progress has been made in cancer biology and treatment, clinical outcomes of bladder carcinoma (BC) patients are still not satisfactory. The tumor microenvironment (TME) is a potential target. Here, by single-cell RNA sequencing on 8 BC samples 3 para samples, we identify 19 different cell types the microenvironment, indicating high intra-tumoral heterogeneity. We find that cells down regulated MHC-II molecules, suggesting downregulated immunogenicity may contribute to formation an immunosuppressive microenvironment. also monocytes undergo M2 polarization region differentiate. Furthermore, LAMP3 + DC subgroup be able recruit regulatory T cells, potentially taking part TME. Through correlation analysis using public datasets containing over 3000 role for inflammatory cancer-associated fibroblasts (iCAFs) progression, which significantly related poor prognosis. Additionally, characterize network depending iCAFs. These results could help elucidate protumor mechanisms Our provide deep insight into immunology essential resource drug discovery future.

Language: Английский

Citations

464

Longitudinal molecular trajectories of diffuse glioma in adults DOI
Floris P Barthel, Kevin C. Johnson, Frederick S. Varn

et al.

Nature, Journal Year: 2019, Volume and Issue: 576(7785), P. 112 - 120

Published: Nov. 20, 2019

Language: Английский

Citations

451

Spatial omics and multiplexed imaging to explore cancer biology DOI
Sabrina M. Lewis, Marie-Liesse Asselin-Labat, Quan Nguyen

et al.

Nature Methods, Journal Year: 2021, Volume and Issue: 18(9), P. 997 - 1012

Published: Aug. 2, 2021

Language: Английский

Citations

451

The multi-factorial nature of clinical multidrug resistance in cancer DOI
Yehuda G. Assaraf, Anamaria Brozović, Ana Cristina Gonçalves

et al.

Drug Resistance Updates, Journal Year: 2019, Volume and Issue: 46, P. 100645 - 100645

Published: Sept. 1, 2019

Language: Английский

Citations

446

Mechanisms generating cancer genome complexity from a single cell division error DOI Open Access
Neil T. Umbreit, Cheng‐Zhong Zhang, Luke D. Lynch

et al.

Science, Journal Year: 2020, Volume and Issue: 368(6488)

Published: April 16, 2020

Genomic havoc from one fateful mistake Many human tumors display scrambled genomes that arise two distinct mutational processes. The first, the chromosome breakage-fusion-bridge (BFB) cycle, produces gene amplification and genomic instability. second, chromothripsis, generates massive, clustered rearrangements in or a few chromosomes. Umbreit et al. hypothesized these processes are mechanistically related tested this idea by recreating essential steps of BFB cycle cultured cells (see Perspective Paiano Nussenzweig). They found chromothripsis arises cascade events begins with aberrant bridge formation during mitosis, followed fragmentation, DNA damage, missegregation, micronuclei. propose model explains how single cell division error (chromosome formation) can generate many hallmark features cancer genomes. Science , issue p. 240 ; see also eaba0712

Language: Английский

Citations

387

Next-generation cancer organoids DOI
Bauer L. LeSavage, Riley A. Suhar, Nicolas Broguière

et al.

Nature Materials, Journal Year: 2021, Volume and Issue: 21(2), P. 143 - 159

Published: Aug. 12, 2021

Language: Английский

Citations

332

Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics DOI
Anna S. Nam, Ronan Chaligné, Dan A. Landau

et al.

Nature Reviews Genetics, Journal Year: 2020, Volume and Issue: 22(1), P. 3 - 18

Published: Aug. 17, 2020

Language: Английский

Citations

316

Immunological impact of cell death signaling driven by radiation on the tumor microenvironment DOI
María E. Rodríguez-Ruiz, Ilio Vitale, Kevin J. Harrington

et al.

Nature Immunology, Journal Year: 2019, Volume and Issue: 21(2), P. 120 - 134

Published: Dec. 23, 2019

Language: Английский

Citations

309

Cell Death in the Origin and Treatment of Cancer DOI Creative Commons
Andreas Strasser, David L. Vaux

Molecular Cell, Journal Year: 2020, Volume and Issue: 78(6), P. 1045 - 1054

Published: June 1, 2020

Cell death, or, more specifically, cell suicide, is a process of fundamental importance to human health. Throughout our lives, over million cells are produced every second. When organismal growth has stopped, balance division, similar number must be removed. This achieved by activation molecular mechanisms that have evolved so can destroy themselves. The first clues regarding the nature one these came from studying genes associated with cancer, in particular gene for BCL-2. Subsequent studies revealed mutations or other defects inhibit death allow accumulate, prevent removal damaged DNA, and increase resistance malignant chemotherapy. Knowledge this mechanism allowed development drugs kill cancer directly activating machinery synergizing conventional chemotherapy as well targeted agents achieve improved outcomes patients. theory, established 1800s, posits all organisms composed derived (reviewed Mazzarello, 1999Mazzarello P. A unifying concept: history theory.Nat. Biol. 1999; 1: E13-E15Crossref PubMed Google Scholar). Since then, it became apparent only multicellular get cancers expand when rate at which divide greater than they die. What surprising die, whether normal cells, seldom because injured killed cells. Rather, most die activate programmed purpose (Kerr et al., 1972Kerr J.F. Wyllie A.H. Currie A.R. Apoptosis: basic biological phenomenon wide-ranging implications tissue kinetics.Br. J. Cancer. 1972; 26: 239-257Crossref Scholar, Vaux 1994Vaux D.L. Haecker G. Strasser A. An evolutionary perspective on apoptosis.Cell. 1994; 76: 777-779Abstract Full Text PDF Scopus (675) been observed long time, but was initially largely reported context necrosis hypoxic areas growing tumors (Thomlinson Gray, 1955Thomlinson R.H. Gray L.H. histological structure some lung possible radiotherapy.Br. 1955; 9: 539-549Crossref also therapy radiation were designed cause comes cost causing many (Ballantyne, 1975Ballantyne A.J. Late sequelae head neck reference nasopharynx.Am. Surg. 1975; 130: 433-436Abstract Katz Glick, 1979Katz M.E. Glick J.H. Nitrosoureas: reappraisal clinical trials.Cancer Clin. Trials. 1979; 2: 297-316PubMed O'Connor, 2015O'Connor M.J. Targeting DNA Damage Response Cancer.Mol. Cell. 2015; 60: 547-560Abstract Kerr Scholar proposed using term "apoptosis" refer result physiological suicide rather catastrophic event (e.g., freezing burning). latter undergo morphologically different They looked apoptosis noting had known characteristic neoplasms. wrote: "Both apoptotic bodies mitotic figures sometimes numerous rapidly tumors; two determines enlargement." foresaw induction treat observing increased squamous carcinomas oophorectomy mammary rats Initially, few researchers took notice their work, late 1980s, things changed. current enormous interest due elucidation its mechanisms, recognition part life metazoans, way conserved worms mammals. In addition, inability themselves linked humans promote Kreeger, 1996Kreeger K.Y. Hot papers: Programmed death.Scientist. 1996; 10: 1Google Although, own, killing itself insufficient become fully malignant, such passed cell's progeny, neoplasia. Normally, detect irreparable damage themselves; example, tumor suppressor p53, transcriptionally inducers Puma Noxa (Nakano Vousden, 2001Nakano K. Vousden K.H. PUMA, novel proapoptotic gene, induced p53.Mol. 2001; 7: 683-694Abstract (1631) Yu 2001Yu Zhang L. Hwang P.M. Kinzler K.W. Vogelstein B. PUMA induces rapid colorectal cells.Mol. 673-682Abstract (1029) Jeffers 2003Jeffers J.R. Parganas E. Lee Y. Yang C. Wang Brennan MacLean Han Chittenden T. Ihle J.N. al.Puma an essential mediator p53-dependent -independent pathways.Cancer 2003; 4: 321-328Abstract (717) Villunger 2003Villunger Michalak E.M. Coultas Müllauer F. Böck Ausserlechner Adams J.M. p53- drug-induced responses mediated BH3-only proteins puma noxa.Science. 302: 1036-1038Crossref (1006) Therefore, incapable themselves, those overexpressing inhibitor BCL-2 may accumulate further genetic advances neoplastic transformation. Loss-of-function p53 would not inducing affect tumor-suppressive functions, including ability repair pathways, cycle arrest senescence (Vousden Lane, 2007Vousden Lane D.P. health disease.Nat. Rev. Mol. 2007; 8: 275-283Crossref (1515) Janic 2018Janic Valente L.J. Wakefield Di Stefano Milla Wilcox S. H. Tai Vandenberg C.J. Kueh al.DNA processes critical mediators suppression.Nat. Med. 2018; 24: 947-953Crossref (32) If receives another mutation promotes aberrant proliferation (for chromosome translocation causes overexpression c-MYC), then combined effect will nascent clone. explains potent synergy overexpression) deregulated c-MYC lymphoma (Vaux 1988Vaux Cory Bcl-2 haemopoietic survival cooperates c-myc immortalize pre-B cells.Nature. 1988; 335: 440-442Crossref 1990Strasser Harris A.W. Bath M.L. Novel primitive lymphoid tumours transgenic mice cooperation between myc bcl-2.Nature. 1990; 348: 331-333Crossref (744) Fanidi 1992Fanidi Harrington E.A. Evan G.I. Cooperative interaction bcl-2 proto-oncogenes.Nature. 1992; 359: 554-556Crossref (684) Bissonnette 1992Bissonnette R.P. Echeverri Mahboubi Green D.R. Apoptotic inhibited 552-554Crossref As grows, instability increases diversity among Treatment selects happen higher threshold triggering intrinsic mechanism. Darwinian selection facilitate emergence treatment (Turajlic 2019Turajlic Sottoriva Graham Swanton Resolving heterogeneity cancer.Nat. Genet. 2019; 20: 404-416Crossref (71) Elucidation use provided new insights into origins malignancy, sensitivity treatment, therapy. Importantly, discoveries identified targets anti-cancer therapies. thoroughly understood variously "intrinsic," "mitochondrial," "BCL-2-regulated," "Bcl-2-associated X protein (BAX)/Bcl-2 homologous antagonist killer (BAK)-dependent" (Figure 1). pathway, BAX and/or BAK allows effectors permeabilize outer mitochondrial membrane (MOMP [mitochondrial permeabilization]) (Cosentino García-Sáez, 2018Cosentino García-Sáez MIM through MOM: awakening Bax Bak pores.EMBO 37: e100340Crossref (0) release cytochrome c cytoplasm, where binds APAF-1 triggers formation apoptosome activates caspase-9 and, consequently, cascade proteolytic effector caspases (Tait Green, 2010Tait S.W. Mitochondria death: permeabilization beyond.Nat. 2010; 11: 621-632Crossref (1495) MOMP facilitates additional apoptogenic factors mitochondria, second mitochondria-derived activator (SMAC)/direct IAP bindong low pl (DIABLO) HTRA2. These inhibiting E3 ubiquitin ligase X-linked (XIAP), caspase-3, (Du 2000Du Fang M. Li X. Smac, c-dependent caspase eliminating inhibition.Cell. 2000; 102: 33-42Abstract Verhagen 2000Verhagen A.M. Ekert P.G. Pakusch Silke Connolly L.M. Reid G.E. Moritz R.L. Simpson R.J. Identification DIABLO, mammalian binding antagonizing proteins.Cell. 43-53Abstract Deveraux 1997Deveraux Q.L. Takahashi R. Salvesen G.S. Reed J.C. direct cell-death proteases.Nature. 1997; 388: 300-304Crossref (1633) Triggering anti-apoptotic family members, itself, B lymphoma-extra large (BCL-XL), MCL-1, BCL-2-like WEHI (BCL-W), A1/BFL-1. Apoptosis initiated bound (i.e., pro-apoptotic BIM, BID, NOXA, BMF, BAD, BLK, HRK), stopping them keeping check (Huang 2019Huang O'Neill K.L. Zhou W. N. Pang Wu Struble Borgstahl Liu Z. al.BH3-only target BCL-xL/MCL-1, BAX/BAK, initiate apoptosis.Cell Res. 29: 942-952Crossref (11) Singh 2019Singh Letai Sarosiek Regulation disease: balancing act proteins.Nat. 175-193Crossref (164) Expression activity response developmental cues stress stimuli variety transcriptional post-transcriptional (Puthalakath Strasser, 2002Puthalakath Keeping killers tight leash: post-translational control proteins.Cell Death Differ. 2002; 505-512Crossref For NOXA damage-induced (Jeffers Shibue 2006Shibue Suzuki Okamoto Yoshida Ohba Takaoka Taniguchi Differential contribution dual regulation p53-mediated pathways.EMBO 2006; 25: 4952-4962Crossref (65) Scholar), BIM required full experiencing stresses, endoplasmic reticulum (ER) stress, cytokine deprivation, glucocorticoid (Bouillet 1999Bouillet Metcalf D. Huang D.C. Tarlinton D.M. Kay T.W. Köntgen Proapoptotic relative Bim certain responses, leukocyte homeostasis, preclude autoimmunity.Science. 286: 1735-1738Crossref (1233) Puthalakath 2007Puthalakath O'Reilly L.A. Gunn Kelly P.N. Huntington N.D. Hughes P.D. McKimm-Breschkin Motoyama al.ER Bim.Cell. 129: 1337-1349Abstract (941) Induction regulated microRNA cluster mir-17-92 (Ventura 2008Ventura Young A.G. Winslow M.M. Lintault Meissner Erkeland S.J. Newman Bronson R.T. Crowley Stone al.Targeted deletion reveals overlapping functions miR-17 92 miRNA clusters.Cell. 2008; 132: 875-886Abstract (1193) Xiao 2008Xiao Srinivasan Calado Patterson H.C. Henderson Kutok J.L. Rajewsky Lymphoproliferative disease autoimmunity miR-17-92 expression lymphocytes.Nat. Immunol. 405-414Crossref (953) strongest evidence oncogenic discovery recurrent encoding regulators diverse cancers. includes upstream initiator processes, ∼50% (Lane, 1992Lane guardian genome.Nature. 358: 15-16Crossref (4115) association t14:18 chromosomal translocations lead follicular (Rowley, 1988Rowley J.D. Chromosome non-Hodgkin's lymphomas: role 14;18 translocation.J. Oncol. 6: 919-925Crossref (82) Tsujimoto 1985Tsujimoto Cossman Jaffe Croce C.M. Involvement lymphoma.Science. 1985; 228: 1440-1443Crossref high chronic lymphocytic leukemias microRNAs miR-15/16 Pekarsky 2018Pekarsky Balatti V. BCL2 miR-15/16: treatment.Cell 21-26Crossref (63) somatically acquired amplifications genomic regions containing MCL-1 BCL-XL 10%–15% (Beroukhim 2010Beroukhim Mermel C.H. Porter Wei Raychaudhuri Donovan Barretina Boehm J.S. Dobson Urashima al.The landscape somatic copy-number alteration across cancers.Nature. 463: 899-905Crossref (2144) addition BAX/BAK-dependent there several but, date, implicating therapeutic considerably weaker. Mammalian caspase-dependent (Strasser 1995Strasser D.C.S. Krammer P.H. Fas/APO-1 regulate distinct pathways lymphocyte apoptosis.EMBO 1995; 14: 6136-6147Crossref Scholar) does require BAK. pathway activated factor (TNF) receptor members (so-called receptors), TNFR1, FAS, TNF-related apoptosis-inducing ligand (TRAIL) receptors (Nagata, 1997Nagata factor.Cell. 88: 355-365Abstract (4401) that, upon ligation, transmit signals via FAS-associated domain (FADD) active caspase-8 (Kischkel 1995Kischkel F.C. Hellbardt Behrmann I. Germer Pawlita Peter Cytotoxicity-dependent APO-1 (Fas/CD95)-associated form death-inducing signaling complex (DISC) receptor.EMBO 5579-5588Crossref (1767) Muzio 1996Muzio Chinnaiyan Kischkel O'Rourke Shevchenko Ni Scaffidi Bretz Gentz al.FLICE, FADD-homologous ICE/CED-3-like protease, recruited CD95 (Fas/APO-1) death--inducing complex.Cell. 85: 817-827Abstract (2629) so-called type 1 mostly sufficient caspases, caspases-3 -7, effectively absence 2 hepatocytes pancreatic islet β requires signal amplification caspase-8-mediated engages BAX/BAK-mediated (Li 1998Li Zhu Xu Yuan Cleavage BID 8 mediates Fas 1998; 94: 491-501Abstract Luo 1998Luo Budihardjo Zou Slaughter Bid, Bcl2 interacting protein, mitochondria surface receptors.Cell. 481-490Abstract 1999Scaffidi Schmitz Zha Korsmeyer modulation I II cells.J. Chem. 274: 22532-22538Crossref Jost 2009Jost P.J. Grabow McKenzie M.D. Nachbur U. Bouillet Thomas H.E. Borner al.XIAP discriminates FAS-induced apoptosis.Nature. 2009; 460: 1035-1039Crossref (302) Scholar; Figure Humans autoimmune lympho-proliferative syndrome (ALPS), caused (mostly FAS itself), predisposition develop malignancies (Straus 2001Straus S.E. E.S. Puck Dale J.K. Elkon K.B. Rösen-Wolff Peters Sneller M.C. Hallahan C.W. lymphomas families lymphoproliferative germline defective apoptosis.Blood. 98: 194-200Crossref (330) demonstrates death-receptor-triggered action. Degterev 2005Degterev Boyce Jagtap Mizushima Cuny G.D. Mitchison T.J. Moskowitz M.A. Chemical nonapoptotic potential ischemic brain injury.Nat. 2005; 112-119Crossref (1554) showed apoptosis, TNF could caspase-independent termed "necroptosis." chose morphology dying resembled necrotic unlike undergoing necrosis, necroptotic being death-receptor-, Toll-like (TLR)-, Z-DNA (ZBP1)-induced abrogated loss drug-mediated inhibition caspase-8), cIAP1/2 ∗E2 ligases pro-survival TNFR1 genetically lost drugs, necroptosis (Festjens 2006Festjens Vanden Berghe Vandenabeele Necrosis, well-orchestrated demise: signalling cascades, important concomitant immune response.Biochim. Biophys. Acta. 1757: 1371-1387Crossref (453) 2016Yuan Najafov Py B.F. Roles Caspases Necrotic Death.Cell. 2016; 167: 1693-1704Abstract (101) kinases RIPK1 RIPK3 (Degterev 2008Degterev Hitomi Germscheid Ch'en I.L. Korkina O. Teng Abbott Wagner al.Identification RIP1 kinase specific cellular necrostatins.Nat. 313-321Crossref (1142) Kaiser 2011Kaiser W.J. Upton J.W. Long A.B. Livingston-Rosanoff Daley-Bauer L.P. Hakem Caspary Mocarski RIP3 embryonic lethality caspase-8-deficient mice.Nature. 2011; 471: 368-372Crossref (626) pseudo-kinase mixed lineage domain-like (MLKL), lytic pores plasma (Sun 2012Sun He Chen Liao Yan Lei Mixed downstream kinase.Cell. 2012; 148: 213-227Abstract (1094) Murphy 2013Murphy Czabotar P.E. Hildebrand Lucet I.S. J.G. Alvarez-Diaz Lewis Lalaoui Webb A.I. pseudokinase MLKL switch mechanism.Immunity. 2013; 39: 443-453Abstract (500) Grootjans 2017Grootjans Initiation execution necroptosis: overview.Cell 2017; 1184-1195Crossref (121) 2). RIPK1, inducer necroptosis, normally neutralized proteolysis (Newton 2019Newton Wickliffe K.E. Dugger Maltzman Roose-Girma Dohse Kőműves Webster Dixit V.M. crucial limiting necroptosis.Nature. 574: 428-431Crossref (42) Necroptosis probably serves defense against viruses carry inhibitors caspase-8, viral Fas-associated interleukin-1β (IL-1β)-converting enzyme-inhibitory (vFLIP) (Thome 1997Thome Schneider Hofmann Fickenscher Meinl Neipel Mattmann Burns Bodmer Schröter al.Viral FLICE-inhibitory (FLIPs) receptors.Nature. 386: 517-521Crossref (1063) Pyroptosis intra-cellular bacteria, Salmonella. It caspase-1, within inflammasome range adaptors Schroder Tschopp, 2010Schroder Tschopp inflammasomes.Cell. 140: 821-832Abstract (3021) caspase-11, lipopolysaccharide (LPS) (Shi 2014Shi Zhao Gao Ding Hu Shao Inflammatory innate intracellular LPS.Nature. 2014; 514: 187-192Crossref (36) pore-forming gasdermin D -7 (Kayagaki 2015Kayagaki Stowe I.B. B.L. Anderson Warming Cuellar Haley Phung Q.T. al.Caspase-11 cleaves non-canonical signalling.Nature. 526: 666-671Crossref (936) Shi 2015Shi Zhuang Cai GSDMD inflammatory pyroptotic death.Nature. 660-665Crossref (1167) 2016Liu Ruan Pan Magupalli V.G. Lieberman Inflammasome-activated pyroptosis forming pores.Nature. 535: 153-158Crossref (606) 3). Cytotoxic T lymphocytes (CTLs) natural (NK) able infected, thereby protect host. CTLs NK enlisted (Khavari, 1987Khavari neoplasia: review.Yale 1987; 409-419PubMed Although cell-autonomous adaptive host's own granule-dependent uses perforin proteases called granzymes access cytosol (Cullen Martin, 2008Cullen S.P. Martin Mechanisms killing.Cell 15: 251-262Crossref (132) Chowdhury Lieberman, 2008Chowdhury thousand cuts: granzyme death.Annu. 389-420Crossref Much excitement enlisting CTL-mediated involves "checkpoint inhibitors" block otherwise limit (Amaravadi 2016Amaravadi Kimmelman A.C. White Recent function autophagy cancer.Genes Dev. 2016

Language: Английский

Citations

304